T-cells Affected by ImmunosuppressantsAlthough there have been advances in cancer research in the past few decades, many cancers still lack adequate forms of treatment. In certain types of cancers, this is due to the ability of tumors to produce immunosuppressive factors that prevent T cells from re.....
[更多]
The CD33 null mouse were first developed in 2001 and in the past thirteen years these have been well-studied and characterized. Commercial entities please use “Ready-to-sign License”
[更多]
